Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Frederiksen

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Ugeskrift for Laeger|February 12, 1979
[Cancer patients' knowledge of their diagnosis. A retrospective study of the incidence of patients attending an outpatient clinic for cancer chemotherapy who were aware of the diagnosis in advance]P L Frederiksen
Cancer Treatment Reports|March 1, 1986
High-dose medroxyprogesterone acetate in patients with renal adenocarcinoma and measurable lung metastases: a phase II studyM Kjaer, P L Frederiksen
Ugeskrift for Laeger|January 22, 1979
[Testicular neoplasms--local increase. An epidemiological study]C Conrad, P L Frederiksen
Lancet (London, England)|September 13, 1986
Epirubicin-induced primary Sjögren's syndromeA Oxholm, P L Frederiksen, P Oxholm
Scandinavian Journal of Clinical and Laboratory Investigation|February 1, 1978
The glomerular filtration rate determined with 99mTc-DTPA and a portable cadmium telluride detectorN Rossing, J Bojsen, P L Frederiksen
Acta Pharmacologica Et Toxicologica|May 1, 1980
The pharmacokinetics of cyclophosphamide in man after treatment with allopurinolJ Witten, P L Frederiksen, H T Mouridsen
International Journal of Radiation Oncology, Biology, Physics|May 1, 1987
Postoperative radiotherapy in stage II and III renal adenocarcinoma. A randomized trial by the Copenhagen Renal Cancer Study GroupM Kjaer, P L Frederiksen, S A Engelholm
Ugeskrift for Laeger|October 23, 1978
[Treatment of drug-resistant metastasizing cancer of the breast with an antiestrogen]P L Frederiksen, A Engelholm, H T Mouridsen
Ugeskrift for Laeger|March 6, 1989
[Is hepatitis B antigenemia a risk in adjuvant cytostatic treatment of breast cancer?]D Rasmussen, P L Frederiksen, P M Larsen, et al.
Acta Pharmacologica Et Toxicologica|October 1, 1978
Studies on the correlation between rate of biotransformation and haematological toxicity of cyclophosphamideH T Mouridsen, J Witten, P L Frederiksen, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Ugeskrift for Laeger|February 12, 1979
[Cancer patients' knowledge of their diagnosis. A retrospective study of the incidence of patients attending an outpatient clinic for cancer chemotherapy who were aware of the diagnosis in advance]P L Frederiksen
Cancer Treatment Reports|March 1, 1986
High-dose medroxyprogesterone acetate in patients with renal adenocarcinoma and measurable lung metastases: a phase II studyM Kjaer, P L Frederiksen
Ugeskrift for Laeger|January 22, 1979
[Testicular neoplasms--local increase. An epidemiological study]C Conrad, P L Frederiksen
Lancet (London, England)|September 13, 1986
Epirubicin-induced primary Sjögren's syndromeA Oxholm, P L Frederiksen, P Oxholm
Scandinavian Journal of Clinical and Laboratory Investigation|February 1, 1978
The glomerular filtration rate determined with 99mTc-DTPA and a portable cadmium telluride detectorN Rossing, J Bojsen, P L Frederiksen
Acta Pharmacologica Et Toxicologica|May 1, 1980
The pharmacokinetics of cyclophosphamide in man after treatment with allopurinolJ Witten, P L Frederiksen, H T Mouridsen
International Journal of Radiation Oncology, Biology, Physics|May 1, 1987
Postoperative radiotherapy in stage II and III renal adenocarcinoma. A randomized trial by the Copenhagen Renal Cancer Study GroupM Kjaer, P L Frederiksen, S A Engelholm
Ugeskrift for Laeger|October 23, 1978
[Treatment of drug-resistant metastasizing cancer of the breast with an antiestrogen]P L Frederiksen, A Engelholm, H T Mouridsen
Ugeskrift for Laeger|March 6, 1989
[Is hepatitis B antigenemia a risk in adjuvant cytostatic treatment of breast cancer?]D Rasmussen, P L Frederiksen, P M Larsen, et al.
Acta Pharmacologica Et Toxicologica|October 1, 1978
Studies on the correlation between rate of biotransformation and haematological toxicity of cyclophosphamideH T Mouridsen, J Witten, P L Frederiksen, et al.
Pageof 2